{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:41:58Z","timestamp":1794328918587,"version":"4.9.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31720103911"],"award-info":[{"award-number":["31720103911"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Inner Mongolia Science & Technology Major Projects"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Parkinson\u2019s disease (PD) is mainly managed by pharmacological therapy (e.g., Benserazide and dopamine agonists). However, prolonged use of these drugs would gradually diminish their dopaminergic effect. Gut dysbiosis was observed in some patients with PD, suggesting close association between the gut microbiome and PD. Probiotics modulate the host\u2019s gut microbiota beneficially. A 3-month randomized, double-blind, placebo-controlled clinical trial was conducted to investigate the beneficial effect of probiotic co-administration in patients with PD. Eighty-two PD patients were recruited and randomly divided into probiotic [\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200948;\n                    <jats:italic>Bifidobacterium animalis<\/jats:italic>\n                    subsp.\n                    <jats:italic>lactis<\/jats:italic>\n                    Probio-M8 (Probio-M8), Benserazide, dopamine agonists] and placebo (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200934; placebo, Benserazide, dopamine agonists) groups. Finally, 45 and 29 patients from Probio-M8 and placebo groups provided complete fecal and serum samples for further omics analysis, respectively. The results showed that Probio-M8 co-administration conferred added benefits by improving sleep quality, alleviating anxiety, and gastrointestinal symptoms. Metagenomic analysis showed that, after the intervention, there were significantly more species-level genome bins (SGBs) of\n                    <jats:italic>Bifidobacterium animalis<\/jats:italic>\n                    ,\n                    <jats:italic>Ruminococcaceae<\/jats:italic>\n                    , and\n                    <jats:italic>Lachnospira<\/jats:italic>\n                    , while less\n                    <jats:italic>Lactobacillus fermentum<\/jats:italic>\n                    and\n                    <jats:italic>Klebsiella oxytoca<\/jats:italic>\n                    in Probio-M8 group (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.05). Interestingly,\n                    <jats:italic>Lactobacillus fermentum<\/jats:italic>\n                    correlated positively with the scores of UPDRS-III, HAMA, HAMD-17, and negatively with MMSE.\n                    <jats:italic>Klebsiella oxytoca<\/jats:italic>\n                    correlated negatively with feces hardness. Moreover, co-administering Probio-M8 increased SGBs involved in tryptophan degradation, gamma-aminobutyric acid, short-chain fatty acids, and secondary bile acid biosynthesis, as well as serum acetic acid and dopamine levels (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.05). Taken together, Probio-M8 synergized with the conventional regimen and strengthened the clinical efficacy in managing PD, accompanied by modifications of the host\u2019s gut microbiome, gut microbial metabolic potential, and serum metabolites.\n                  <\/jats:p>","DOI":"10.1038\/s41531-022-00327-6","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T06:02:46Z","timestamp":1653372166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":134,"title":["Probiotics synergized with conventional regimen in managing Parkinson\u2019s disease"],"prefix":"10.1038","volume":"8","author":[{"given":"Hairong","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7360-5436","authenticated-orcid":false,"given":"Feiyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2965-0739","authenticated-orcid":false,"given":"Hao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyu","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai-Yu","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shukun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"key":"327_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5056\/jnm17105","volume":"24","author":"AT Nair","year":"2018","unstructured":"Nair, A. T. et al. Gut microbiota dysfunction as reliable non-invasive early diagnostic biomarkers in the pathophysiology of Parkinson\u2019s disease: a critical review. J. Neurogastroenterol. Motil. 24, 30\u201342 (2018).","journal-title":"J. Neurogastroenterol. Motil."},{"key":"327_CR2","doi-asserted-by":"publisher","first-page":"G529","DOI":"10.1152\/ajpgi.00058.2020","volume":"319","author":"Y Bhattarai","year":"2020","unstructured":"Bhattarai, Y. & Kashyap, P. C. Parkinson\u2019s disease: are gut microbes involved? Am. J. Physiol. Gastrointest. Liver Physiol. 319, G529\u2013G540 (2020).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"327_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00439-2","volume":"16","author":"M Gries","year":"2021","unstructured":"Gries, M. et al. Parkinson mice show functional and molecular changes in the gut long before motoric disease onset. Mol. Neurodegeneration 16, 23 (2021).","journal-title":"Mol. Neurodegeneration"},{"key":"327_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s13679-016-0191-1","volume":"5","author":"J Ochoa-Reparaz","year":"2016","unstructured":"Ochoa-Reparaz, J. & Kasper, L. H. The second brain: is the gut microbiota a link between obesity and central nervous system disorders? Curr. Obes. Rep. 5, 51\u201364 (2016).","journal-title":"Curr. Obes. Rep."},{"key":"327_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41531-020-0112-6","volume":"6","author":"ZD Wallen","year":"2020","unstructured":"Wallen, Z. D. et al. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. Npj Parkinsons Dis. 6, 12 (2020).","journal-title":"Npj Parkinsons Dis."},{"key":"327_CR6","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/mds.28052","volume":"35","author":"MS Cirstea","year":"2020","unstructured":"Cirstea, M. S. et al. Microbiota composition and metabolism are associated with gut function in Parkinson\u2019s disease. Mov. Disord. 35, 1208\u20131217 (2020).","journal-title":"Mov. Disord."},{"key":"327_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41531-021-00156-z","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano, S. et al. Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. Npj Parkinsons Dis. 7, 13 (2021).","journal-title":"Npj Parkinsons Dis."},{"key":"327_CR8","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan, J. F. et al. The microbiota-gut-brain axis. Physiol. Rev. 99, 1877\u20132013 (2019).","journal-title":"Physiol. Rev."},{"key":"327_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist, S. et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 128, 805\u2013820 (2014).","journal-title":"Acta Neuropathol."},{"key":"327_CR10","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson, T. R. et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167, 1469 (2016).","journal-title":"Cell"},{"key":"327_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.molcel.2020.03.006","volume":"78","author":"KG Jameson","year":"2020","unstructured":"Jameson, K. G. et al. Toward understanding microbiome-neuronal signaling. Mol. Cell 78, 577\u2013583 (2020).","journal-title":"Mol. Cell"},{"key":"327_CR12","first-page":"666","volume":"1","author":"M Boehme","year":"2021","unstructured":"Boehme, M. et al. Microbiota from young mice counteracts selective age-associated behavioral deficits. Food Behav. Res. 1, 666\u201367 (2021).","journal-title":"Food Behav. Res."},{"key":"327_CR13","first-page":"1055","volume":"364","author":"VM Rekdal","year":"2019","unstructured":"Rekdal, V. M. et al. Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science 364, 1055 (2019).","journal-title":"Science"},{"key":"327_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41467-018-07826-2","volume":"10","author":"SP van Kessel","year":"2019","unstructured":"van Kessel, S. P. et al. Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson\u2019s disease. Nat. Commun. 10, 11 (2019).","journal-title":"Nat. Commun."},{"key":"327_CR15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41564-018-0307-3","volume":"4","author":"P Strandwitz","year":"2019","unstructured":"Strandwitz, P. et al. GABA-modulating bacteria of the human gut microbiota. Nat. Microbiol. 4, 396\u2013403 (2019).","journal-title":"Nat. Microbiol."},{"key":"327_CR16","first-page":"11","volume":"140","author":"XY Zhao","year":"2021","unstructured":"Zhao, X. Y. et al. Baicalein alleviates depression-like behavior in rotenone- induced Parkinson\u2019s disease model in mice through activating the BDNF\/TrkB\/CREB pathway. Biomed. Pharmacother. 140, 11 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"327_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.lfs.2020.117345","volume":"245","author":"YS Feng","year":"2020","unstructured":"Feng, Y. S. et al. The benefits and mechanisms of exercise training for Parkinson\u2019s disease. Life Sci. 245, 10 (2020).","journal-title":"Life Sci."},{"key":"327_CR18","doi-asserted-by":"publisher","first-page":"676827","DOI":"10.3389\/fnagi.2021.676827","volume":"13","author":"X Wen","year":"2021","unstructured":"Wen, X. et al. Acupuncture-related therapies for Parkinson\u2019s disease: a meta-analysis and qualitative review. Front. Aging Neurosci. 13, 676827 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"327_CR19","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill, C. et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11, 506\u2013514 (2014).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"327_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/brainsci10040206","volume":"10","author":"T-H Hsieh","year":"2020","unstructured":"Hsieh, T.-H. et al. Probiotics alleviate the progressive deterioration of motor functions in a mouse model of Parkinson\u2019s disease. Brain Sci. 10, 206 (2020).","journal-title":"Brain Sci."},{"key":"327_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13568-020-01014-6","volume":"10","author":"X Fang","year":"2020","unstructured":"Fang, X. et al. Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer\u2019s disease and Parkinson\u2019s disease. Amb. Express 10, 13 (2020).","journal-title":"Amb. Express"},{"key":"327_CR22","first-page":"117","volume":"57","author":"E Cassani","year":"2011","unstructured":"Cassani, E. et al. Use of probiotics for the treatment of constipation in Parkinson\u2019s disease patients. Minerva Gastroenterol. Dietol. 57, 117\u2013121 (2011).","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"327_CR23","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1212\/WNL.0000000000003127","volume":"87","author":"M Barichella","year":"2016","unstructured":"Barichella, M. et al. Probiotics and prebiotic fiber for constipation associated with Parkinson disease: an RCT. Neurology 87, 1274\u20131280 (2016).","journal-title":"Neurology"},{"key":"327_CR24","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.clnu.2018.05.018","volume":"38","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji, O. R. et al. Clinical and metabolic response to probiotic administration in people with Parkinson\u2019s disease: a randomized, double-blind, placebo-controlled trial. Clin. Nutr. 38, 1031\u20131035 (2019).","journal-title":"Clin. Nutr."},{"key":"327_CR25","doi-asserted-by":"publisher","first-page":"E772","DOI":"10.1212\/WNL.0000000000011652","volume":"96","author":"AH Tan","year":"2021","unstructured":"Tan, A. H. et al. Probiotics for constipation in Parkinson disease: a randomized placebo-controlled study. Neurology 96, E772\u2013E782 (2021).","journal-title":"Neurology"},{"key":"327_CR26","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.2147\/CIA.S106284","volume":"11","author":"D Georgescu","year":"2016","unstructured":"Georgescu, D. et al. Nonmotor gastrointestinal disorders in older patients with Parkinson\u2019s disease: is there hope? Clin. Interven. Aging 11, 1601\u20131608 (2016).","journal-title":"Clin. Interven. Aging"},{"key":"327_CR27","first-page":"17","volume":"15","author":"A Ibrahim","year":"2020","unstructured":"Ibrahim, A. et al. Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson\u2019s disease: a randomised controlled trial. PLos ONE 15, 17 (2020).","journal-title":"PLos ONE"},{"key":"327_CR28","first-page":"289","volume":"21","author":"S Borzabadi","year":"2018","unstructured":"Borzabadi, S. et al. The effects of probiotic supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson\u2019s disease: a randomized, double-blind, placebo-controlled trial. Arch. Iran. Med. 21, 289\u2013295 (2018).","journal-title":"Arch. Iran. Med."},{"key":"327_CR29","doi-asserted-by":"publisher","first-page":"8791","DOI":"10.3168\/jds.2019-18049","volume":"103","author":"W Zhang","year":"2020","unstructured":"Zhang, W. et al. Short communication: modulation of fatty acid metabolism improves oxygen tolerance of Bifidobacterium animalis ssp. lactis Probio-M8. J. Dairy Sci. 103, 8791\u20138795 (2020).","journal-title":"J. Dairy Sci."},{"key":"327_CR30","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1007\/s00394-021-02543-x","volume":"60","author":"JN Cao","year":"2021","unstructured":"Cao, J. N. et al. Bifidobacterium Lactis Probio-M8 regulates gut microbiota to alleviate Alzheimer\u2019s disease in the APP\/PS1 mouse model. Eur. J. Nutr. 60, 3757\u20133769 (2021).","journal-title":"Eur. J. Nutr."},{"key":"327_CR31","first-page":"14","volume":"11","author":"JC Zhang","year":"2020","unstructured":"Zhang, J. C. et al. Probiotics maintain the intestinal microbiome homeostasis of the sailors during a long sea voyage. Gut Microbes 11, 14 (2020).","journal-title":"Gut Microbes"},{"key":"327_CR32","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41564-018-0337-x","volume":"4","author":"M Valles-Colomer","year":"2019","unstructured":"Valles-Colomer, M. et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat. Microbiol. 4, 623\u2013632 (2019).","journal-title":"Nat. Microbiol."},{"key":"327_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/metabo7040062","volume":"7","author":"J Chong","year":"2017","unstructured":"Chong, J. & Xia, J. G. Computational approaches for integrative analysis of the metabolome and microbiome. Metabolites 7, 10 (2017).","journal-title":"Metabolites"},{"key":"327_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/brainsci10040206","volume":"10","author":"TH Hsieh","year":"2020","unstructured":"Hsieh, T. H. et al. Probiotics alleviate the progressive deterioration of motor functions in a mouse model of Parkinson\u2019s disease. Brain Sci. 10, 13 (2020).","journal-title":"Brain Sci."},{"key":"327_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41392-020-00357-7","volume":"6","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Oral berberine improves brain dopa\/dopamine levels to ameliorate Parkinson\u2019s disease by regulating gut microbiota. Signal Transduct. Target. Ther. 6, 20 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"327_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41531-016-0002-0","volume":"3","author":"MC Houser","year":"2017","unstructured":"Houser, M. C. & Tansey, M. G. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson\u2019s disease pathogenesis? Npj Parkinsons Dis. 3, 9 (2017).","journal-title":"Npj Parkinsons Dis."},{"key":"327_CR37","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMoa0809335","volume":"361","author":"CW Olanow","year":"2009","unstructured":"Olanow, C. W. et al. A double-blind, delayed-start trial of rasagiline in Parkinson\u2019s disease. N. Engl. J. Med. 361, 1268\u20131278 (2009).","journal-title":"N. Engl. J. Med."},{"key":"327_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3389-1","volume":"20","author":"PD Browne","year":"2019","unstructured":"Browne, P. D. et al. Probiotics in pregnancy: protocol of a double-blind randomized controlled pilot trial for pregnant women with depression and anxiety (PIP pilot trial). Trials 20, 21 (2019).","journal-title":"Trials"},{"key":"327_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12937-016-0198-1","volume":"15","author":"L Otstlund-Lagerstrom","year":"2016","unstructured":"Otstlund-Lagerstrom, L. et al. Probiotic administration among free-living older adults: a double blinded, randomized, placebo-controlled clinical trial. Nutr. J. 15, 80 (2016).","journal-title":"Nutr. J."},{"key":"327_CR40","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.18632\/aging.102810","volume":"12","author":"HY Deng","year":"2020","unstructured":"Deng, H. Y. et al. Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer\u2019s disease or mild cognitive impairment - a meta-analysis of randomized controned trials. Aging 12, 4010\u20134039 (2020).","journal-title":"Aging"},{"key":"327_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/gerona\/glaa090","volume":"76","author":"CS Kim","year":"2021","unstructured":"Kim, C. S. et al. Probiotic supplementation improves cognitive function and mood with changes in gut microbiota in community-dwelling older adults: a randomized, double-blind, placebo-controlled, multicenter trial. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 76, 32\u201340 (2021).","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"key":"327_CR42","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/j.clnu.2018.09.010","volume":"38","author":"LC Lew","year":"2019","unstructured":"Lew, L. C. et al. Probiotic Lactobacillus plantarum P8 alleviated stress and anxiety while enhancing memory and cognition in stressed adults: a randomised, double-blind, placebo-controlled study. Clin. Nutr. 38, 2053\u20132064 (2019).","journal-title":"Clin. Nutr."},{"key":"327_CR43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ynstr.2021.100294","volume":"14","author":"T Ma","year":"2021","unstructured":"Ma, T. et al. Probiotic consumption relieved human stress and anxiety symptoms possibly via modulating the neuroactive potential of the gut microbiota. Neurobiol. Stress 14, 10 (2021).","journal-title":"Neurobiol. Stress"},{"key":"327_CR44","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.cell.2020.08.007","volume":"182","author":"RAT Mars","year":"2020","unstructured":"Mars, R. A. T. et al. Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable bowel syndrome. Cell 182, 1460 (2020).","journal-title":"Cell"},{"key":"327_CR45","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/ajcn\/nqab078","volume":"114","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Diet quality, gut microbiota, and microRNAs associated with mild cognitive impairment in middle-aged and elderly Chinese population. Am. J. Clin. Nutr. 114, 429\u2013440 (2021).","journal-title":"Am. J. Clin. Nutr."},{"key":"327_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/gutjnl-2015-309618","volume":"65","author":"D Vandeputte","year":"2016","unstructured":"Vandeputte, D. et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65, 57\u201362 (2016).","journal-title":"Gut"},{"key":"327_CR47","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","volume":"44","author":"VTE Aho","year":"2019","unstructured":"Aho, V. T. E. et al. Gut microbiota in Parkinson\u2019s disease: temporal stability and relations to disease progression. Ebiomedicine 44, 691\u2013707 (2019).","journal-title":"Ebiomedicine"},{"key":"327_CR48","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.chom.2020.12.012","volume":"29","author":"C Tanes","year":"2021","unstructured":"Tanes, C. et al. Role of dietary fiber in the recovery of the human gut microbiome and its metabolome. Cell Host Microbe 29, 394 (2021).","journal-title":"Cell Host Microbe"},{"key":"327_CR49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mnfr.201801012","volume":"63","author":"A Kaur","year":"2019","unstructured":"Kaur, A. et al. Physical inaccessibility of a resistant starch shifts mouse gut microbiota to butyrogenic firmicutes. Mol. Nutr. Food Res. 63, 8 (2019).","journal-title":"Mol. Nutr. Food Res."},{"key":"327_CR50","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nature09944","volume":"473","author":"M Arumugam","year":"2011","unstructured":"Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174\u2013180 (2011).","journal-title":"Nature"},{"key":"327_CR51","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11011-009-9139-4","volume":"24","author":"EF dos Santos","year":"2009","unstructured":"dos Santos, E. F. et al. Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in ParkinsonCs disease. Metab. Brain Dis. 24, 257\u2013269 (2009).","journal-title":"Metab. Brain Dis."},{"key":"327_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pep.2013.10.018","volume":"94","author":"K Zhang","year":"2014","unstructured":"Zhang, K. & Ni, Y. Tyrosine decarboxylase from Lactobacillus brevis: Soluble expression and characterization. Protein Expr. Purif. 94, 33\u201339 (2014).","journal-title":"Protein Expr. Purif."},{"key":"327_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01309-7","volume":"11","author":"EE Noble","year":"2021","unstructured":"Noble, E. E. et al. Gut microbial taxa elevated by dietary sugar disrupt memory function. Transl. Psychiatry 11, 16 (2021).","journal-title":"Transl. Psychiatry"},{"key":"327_CR54","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41385-018-0042-3","volume":"11","author":"HM Jang","year":"2018","unstructured":"Jang, H. M. et al. Evidence for interplay among antibacterial-induced gut microbiota disturbance, neuro-inflammation, and anxiety in mice. Mucosal Immunol. 11, 1386\u20131397 (2018).","journal-title":"Mucosal Immunol."},{"key":"327_CR55","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1073\/pnas.1819154116","volume":"116","author":"K Unterhauser","year":"2019","unstructured":"Unterhauser, K. et al. Klebsiella oxytoca enterotoxins tilimycin and tilivalline have distinct host DNA-damaging and microtubule-stabilizing activities. Proc. Natl Acad. Sci. USA 116, 3774\u20133783 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"327_CR56","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41467-021-21669-4","volume":"12","author":"E Sinclair","year":"2021","unstructured":"Sinclair, E. et al. Metabolomics of sebum reveals lipid dysregulation in Parkinson\u2019s disease. Nat. Commun. 12, 9 (2021).","journal-title":"Nat. Commun."},{"key":"327_CR57","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.25982","volume":"89","author":"AH Tan","year":"2021","unstructured":"Tan, A. H. et al. Gut microbial ecosystem in Parkinson disease: new clinicobiological insights from multi-omics. Ann. Neurol. 89, 546\u2013559 (2021).","journal-title":"Ann. Neurol."},{"key":"327_CR58","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/jamaneurol.2019.4611","volume":"77","author":"S Mullin","year":"2020","unstructured":"Mullin, S. et al. Ambroxol for the treatment of patients with Parkinson disease with and without glucocerebrosidase gene mutations: a nonrandomized, noncontrolled trial. JAMA Neurol. 77, 427\u2013434 (2020).","journal-title":"JAMA Neurol."},{"key":"327_CR59","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neulet.2018.03.064","volume":"675","author":"SA Crooks","year":"2018","unstructured":"Crooks, S. A. et al. Carnitine levels and mutations in the SLC22A5 gene in Faroes patients with Parkinson\u2019s disease. Neurosci. Lett. 675, 116\u2013119 (2018).","journal-title":"Neurosci. Lett."},{"key":"327_CR60","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3389\/fphar.2018.01354","volume":"9","author":"W Feng","year":"2018","unstructured":"Feng, W., Ao, H. & Peng, C. Gut microbiota, short-chain fatty acids, and herbal medicines. Front. Pharmacol. 9, 1354 (2018).","journal-title":"Front. Pharmacol."},{"key":"327_CR61","doi-asserted-by":"publisher","first-page":"G361","DOI":"10.1152\/ajpgi.00283.2019","volume":"318","author":"M Muller","year":"2020","unstructured":"Muller, M. et al. Distal colonic transit is linked to gut microbiota diversity and microbial fermentation in humans with slow colonic transit. Am. J. Physiol.Gastrointest. Liver Physiol. 318, G361\u2013G369 (2020).","journal-title":"Am. J. Physiol.Gastrointest. Liver Physiol."},{"key":"327_CR62","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pharmthera.2021.107861","volume":"226","author":"XY Mao","year":"2021","unstructured":"Mao, X. Y. et al. Dietary nutrition for neurological disease therapy: current status and future directions. Pharmacol. Therapeutics 226, 22 (2021).","journal-title":"Pharmacol. Therapeutics"},{"key":"327_CR63","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1042\/bj20030002","volume":"372","author":"L Caldovic","year":"2003","unstructured":"Caldovic, L. & Tuchman, M. N-acetylglutamate and its changing role through evolution. Biochem. J. 372, 279\u2013290 (2003).","journal-title":"Biochem. J."},{"key":"327_CR64","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00726-017-2409-2","volume":"49","author":"A Haghikia","year":"2017","unstructured":"Haghikia, A. et al. The role of L-arginine\/L-homoarginine\/nitric oxide pathway for aortic distensibility and intima-media thickness in stroke patients. Amino Acids 49, 1111\u20131121 (2017).","journal-title":"Amino Acids"},{"key":"327_CR65","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41586-019-1688-z","volume":"574","author":"G Faraco","year":"2019","unstructured":"Faraco, G. et al. Dietary salt promotes cognitive impairment through tau phosphorylation. Nature 574, 686 (2019).","journal-title":"Nature"},{"key":"327_CR66","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1038\/s41366-021-00888-1","volume":"45","author":"E Handakas","year":"2021","unstructured":"Handakas, E. et al. Cord blood metabolic signatures predictive of childhood overweight and rapid growth. Int. J. Obes. 45, 2252\u20132260 (2021).","journal-title":"Int. J. Obes."},{"key":"327_CR67","first-page":"8","volume":"118","author":"J Kobayashi","year":"2021","unstructured":"Kobayashi, J. et al. Cholestenone functions as an antibiotic against Helicobacter pylori by inhibiting biosynthesis of the cell wall component CGL. Proc. Natl Acad. Sci. USA 118, 8 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"327_CR68","first-page":"9","volume":"364","author":"J Kreit","year":"2017","unstructured":"Kreit, J. Microbial catabolism of sterols: focus on the enzymes that transform the sterol 3 beta-hydroxy-5-en into 3-keto-4-en. Fems Microbiol. Lett. 364, 9 (2017).","journal-title":"Fems Microbiol. Lett."},{"key":"327_CR69","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131599. (2015).","journal-title":"Mov. Disord."},{"key":"327_CR70","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1053\/j.gastro.2016.02.014","volume":"150","author":"OS Palsson","year":"2016","unstructured":"Palsson, O. S. et al. Development and validation of the Rome IV Diagnostic Questionnaire for adults. Gastroenterology 150, 1481\u20131491 (2016).","journal-title":"Gastroenterology"},{"key":"327_CR71","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/mds.22197","volume":"23","author":"CA Haaxma","year":"2008","unstructured":"Haaxma, C. A. et al. Comparison of a timed motor test battery to the Unified Parkinson\u2019s Disease Rating Scale-III in Parkinson\u2019s disease. Mov. Disord. 23, 1707\u20131717 (2008).","journal-title":"Mov. Disord."},{"key":"327_CR72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1017\/neu.2014.33","volume":"27","author":"T Ozcan","year":"2015","unstructured":"Ozcan, T. et al. The relation of sexual dysfunction to depression and anxiety in patients with Parkinson\u2019s disease. Acta Neuropsychiatr. 27, 33\u201337 (2015).","journal-title":"Acta Neuropsychiatr."},{"key":"327_CR73","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jns.2009.09.015","volume":"287","author":"Y Uemura","year":"2009","unstructured":"Uemura, Y. et al. Validation of the Parkinson\u2019s disease sleep scale in Japanese patients: a comparison study using the Pittsburgh Sleep Quality Index, the Epworth Sleepiness Scale and Polysomnography. J. Neurol. Sci. 287, 36\u201340 (2009).","journal-title":"J. Neurol. Sci."},{"key":"327_CR74","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000331911","volume":"37","author":"T Mueller","year":"2011","unstructured":"Mueller, T., Muhlack, S. & Woitalla, D. Pain perception, pain drug therapy and health status in patients with Parkinson\u2019s disease. Neuroepidemiology 37, 183\u2013187 (2011).","journal-title":"Neuroepidemiology"},{"key":"327_CR75","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12877-020-01574-z","volume":"20","author":"G Gefenaite","year":"2020","unstructured":"Gefenaite, G. et al. Longitudinal association between housing accessibility and activities of daily living: the role of self-efficacy and control in people ageing with Parkinson\u2019s disease. BMC Geriatr. 20, 181 (2020).","journal-title":"BMC Geriatr."},{"key":"327_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-021-01589-0","volume":"20","author":"XY Kuai","year":"2021","unstructured":"Kuai, X. Y. et al. Evaluation of fecal microbiota transplantation in Parkinson\u2019s disease patients with constipation. Microb. Cell Factories 20, 9 (2021).","journal-title":"Microb. Cell Factories"},{"key":"327_CR77","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.biopsych.2013.05.001","volume":"74","author":"TG Dinan","year":"2013","unstructured":"Dinan, T. G., Stanton, C. & Cryan, J. F. Psychobiotics: a novel class of psychotropic. Biol. Psychiatry 74, 720\u2013726 (2013).","journal-title":"Biol. Psychiatry"},{"key":"327_CR78","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013U54. (2012).","journal-title":"Nat. Methods"},{"key":"327_CR79","first-page":"13","volume":"7","author":"DWD Kang","year":"2019","unstructured":"Kang, D. W. D. et al. MetaBAT 2: an adaptive binning algorithm for robust and efficient genome reconstruction from metagenome assemblies. Peerj 7, 13 (2019).","journal-title":"Peerj"},{"key":"327_CR80","doi-asserted-by":"crossref","unstructured":"Vasimuddin, M. et al. Efficient architecture-aware acceleration of BWA-MEM for multicore systems. In 33rd IEEE International Parallel and Distributed Processing Symposium (IPDPS). (IEEE, 2019)","DOI":"10.1109\/IPDPS.2019.00041"},{"key":"327_CR81","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"327_CR82","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1101\/gr.186072.114","volume":"25","author":"DH Parks","year":"2015","unstructured":"Parks, D. H. et al. CheckM: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes. Genome Res. 25, 1043\u20131055 (2015).","journal-title":"Genome Res."},{"key":"327_CR83","doi-asserted-by":"publisher","first-page":"e0085921","DOI":"10.1128\/Spectrum.00859-21","volume":"9","author":"A Liu","year":"2021","unstructured":"Liu, A. et al. Adjunctive probiotics alleviates asthmatic symptoms via modulating the gut microbiome and serum metabolome. Microbiol. Spectr. 9, e0085921 (2021).","journal-title":"Microbiol. Spectr."},{"key":"327_CR84","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1038\/ismej.2017.126","volume":"11","author":"MR Olm","year":"2017","unstructured":"Olm, M. R. et al. dRep: a tool for fast and accurate genomic comparisons that enables improved genome recovery from metagenomes through de-replication. Isme J. 11, 2864\u20132868 (2017).","journal-title":"Isme J."},{"key":"327_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1891-0","volume":"20","author":"DE Wood","year":"2019","unstructured":"Wood, D. E., Lu, J. & Langmead, B. Improved metagenomic analysis with Kraken 2. Genome Biol. 20, 13 (2019).","journal-title":"Genome Biol."},{"key":"327_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-119","volume":"11","author":"D Hyatt","year":"2010","unstructured":"Hyatt, D. et al. Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinforma. 11, 11 (2010).","journal-title":"BMC Bioinforma."},{"key":"327_CR87","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ismej.2015.188","volume":"10","author":"Y Darzi","year":"2016","unstructured":"Darzi, Y. et al. Towards biome-specific analysis of meta-omics data. ISME J. 10, 1025\u20131028 (2016).","journal-title":"ISME J."},{"key":"327_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10927-1","volume":"10","author":"H Mallick","year":"2019","unstructured":"Mallick, H. et al. Predictive metabolomic profiling of microbial communities using amplicon or metagenomic sequences. Nat. Commun. 10, 11 (2019).","journal-title":"Nat. Commun."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-022-00327-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-022-00327-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-022-00327-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T09:16:48Z","timestamp":1669281408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-022-00327-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["327"],"URL":"https:\/\/doi.org\/10.1038\/s41531-022-00327-6","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,24]]},"assertion":[{"value":"23 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}